Business Context and Reporting Period
Company: Global Medical REIT Inc. (GMRE)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 31, 2025
Business Overview: An internally managed REIT that acquires healthcare facilities and leases them to physician groups and healthcare systems. The company operates as a single reportable segment.
Key Financial Metrics
| Metric (in thousands, except per share) | Q1 2025 | Q1 2024 |
|---|---|---|
| Total Revenue | $34,618 | $35,118 |
| Net Income | $3,737 | $2,314 |
| Net Income Attributable to Common Stockholders | $2,104 | $794 |
| Diluted EPS (Common) | $0.03 | $0.01 |
| FFO (Common & NCI) | $14,779 | $14,883 |
| AFFO (Common & NCI) | $16,019 | $16,529 |
| Net Cash Provided by Operating Activities | $12,272 | $14,293 |
| Total Debt (Net) | $677,030 | $646,131 |
| Cash and Restricted Cash | $7,588 | $7,806 |
| Weighted Avg Interest Rate | 3.84% | 3.75% |
Material Changes vs. Prior Period
- Revenue: Total revenue decreased by $0.5 million (1.4%) primarily due to property dispositions completed in the prior year, partially offset by new acquisitions.
- Net Income: Increased by $1.4 million (61.5%) driven largely by a $1.358 million gain on the sale of two investment properties (Derby, KS and Coos Bay, OR), which had no comparable gain in Q1 2024.
- Expenses: General and administrative expenses decreased by $0.8 million, primarily due to a reduction in non-cash LTIP compensation expense following the CEO transition agreement. Interest expense increased by $0.3 million due to higher average borrowings.
- Portfolio Activity: Completed three acquisitions totaling $31.5 million and two dispositions generating $8.2 million in gross proceeds.
Outlook, Risks, and Management Commentary
- Dividends: The company paid $0.21 per share on common stock and $0.46875 per share on Series A Preferred Stock for the quarter.
- Liquidity: As of May 6, 2025, the company had $187 million of unutilized borrowing capacity under its $900 million Credit Facility. Cash balances decreased slightly due to acquisitions and dividend payments.
- Interest Rate Risk: Management notes that while the Federal Reserve lowered rates in late 2024, long-term Treasury yields and SOFR swap rates have increased. Refinancing Term Loan A (maturing April 2026) may result in higher swap rates.
- Tenant Risk (Prospect Medical Group): A major tenant, Prospect Medical Group, filed for Chapter 11 bankruptcy in January 2025. The company reached an agreement regarding the rejection of the lease at the East Orange, NJ facility, waiving post-petition amounts for March 2025. The status of remaining leases with this tenant remains uncertain.
- Market Trends: Management cites an aging population and a shift to outpatient care as positive trends, while elevated interest rates and healthcare wage inflation remain headwinds.
Investor Verification Checklist
- Prospect Medical Group Resolution: Verify the final outcome of the bankruptcy proceedings regarding the remaining leases with Prospect Medical Group and potential unsecured claims.
- Debt Refinancing Costs: Assess the impact of rising long-term interest rates on the refinancing of Term Loan A ($350 million) maturing in April 2026.
- Acquisition Pipeline: Confirm the status and financial terms of the remaining two properties in the five-property portfolio acquired in April 2025.
- FFO/AFFO Sustainability: Review the reconciliation of Net Income to FFO/AFFO to ensure the gain on sale of properties is appropriately excluded from recurring operational metrics.
- CEO Transition Costs: Monitor the cash impact of the Transition and Separation Agreement with former CEO Jeffrey Busch on future liquidity.